Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tm Bioscience to supply Tag-It tests to the University of Medicine and Dentistry of New Jersey:

This article was originally published in Clinica

Executive Summary

Toronto, Canada-based diagnostics company Tm Bioscience has agreed to supply the University of Medicine and Dentistry of New Jersey (UMDNJ) with its Tag-It CTFR 40+4 mutation detection test for cystic fibrosis. The assay is developed to simultaneously screen for 25 cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and four variants as well as 15 of the world's most common and North American-prevalent mutations. UMDNJ says it plans to adopt Tm Bioscience's other tests which are available on the company's standardised genetic testing platform.

You may also be interested in...

Germany Approves Unified Patent Court Ratification Bill

The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.

IHP Launches Funding Campaign

UK-based charity International Health Partners has launched a fresh appeal to double the value funds being raised to send essential medicines to expectant mothers and children at risk of death in areas of extreme deprivation.

Pfizer And Moderna Under Pressure To Agree Vaccine Supplies For Developing Nations

As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts